Krankheitslast von Lungenkrebs in Deutschland: Epidemiologie und Kosten

[1]  M. Schlander,et al.  Krankheitslast von Prostatakrebs in Deutschland: Epidemiologie und Kosten , 2022, Forum.

[2]  M. Schlander,et al.  Messung der Kosten von Krebserkrankungen in Deutschland , 2021, Forum.

[3]  F. Barlesi,et al.  Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). , 2018, Lung cancer.

[4]  E. Emanuel,et al.  Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. , 2016, JAMA.

[5]  Reiner Leidl,et al.  Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens. , 2015, Lung cancer.

[6]  Jacek Jassem,et al.  Caring for relatives with lung cancer in Europe: an evaluation of caregivers’ experience , 2015, Quality of Life Research.

[7]  A. Mcguire,et al.  Treatment cost of non-small cell lung cancer in three European countries: comparisons across France, Germany, and England using administrative databases , 2015, Journal of medical economics.

[8]  C. Peschel,et al.  The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients , 2013, Supportive Care in Cancer.

[9]  C. Peschel,et al.  Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  F. Stanzel,et al.  Geschlechtsspezifische Unterschiede beim Lungenkarzinom , 2013, TumorDiagnostik & Therapie.